Furthermore, by deacetylating important metabolic enzymes like PDH and IDH2, mitochondria-localized SIRT3 improves the effectiveness of oxidative phosphorylation, a mechanism that aids AML cells’ survival in a low-glycemic milieu. Here, IDH2 is linked to acute myeloid leukemia.